Skip to main content
Premium Trial:

Request an Annual Quote

UAlbany RNA Institute Begins Collaborations with Wadsworth Center, Rensselaer Polytechnic


The University at Albany this week announced that scientists from its RNA Institute have begun collaborating with researchers from the Wadsworth Center of the New York State Department of Health and Rensselaer Polytechnic Institute to advance new biomedical technologies.

The RNA Institute was founded in 2010 as a “national research resource for RNA basic fundamental science and RNA technology development in areas that will support biomedical science, drug discovery, and diagnostics,” according to its director, Paul Agris (GSN 12/13/2012).

In line with this, the institute has begun working with the Wadsworth Center and Rensselaer through its interdisciplinary pilot program in order to “identify early-stage, interdisciplinary research that holds potential to generate external research funding or commercial applications,” it said.

Among the new collaborations are ones between UAlbany researchers Daniele Fabris and Wadsworth's Joan Curcio, who are studying Ty1RNA, an RNA molecule potentially involved in cancer and aging; Agris and Wadsworth's Kathleen McDonough, focused on developing a new class of antibiotics for drug-resistant bacteria; UAlbany's Igor Lednev and Rensselaer's Angel Garcia, who are developing ultraviolet resonance Raman spectroscopy technology for RNA structure characterization; and between UAlbany's Pan Li and Gracia studying RNA folding and interactions.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more